Psoriasis comorbidities (Q37084274)

18 August 2017

1 reference

title

Psoriasis comorbidities (English)

1 reference

18 August 2017

1 reference

Alice B Gottlieb

1 reference

18 August 2017

Chun Chao

series ordinal

1 reference

18 August 2017

Frank Dann

series ordinal

1 reference

18 August 2017

publication date

1 January 2008

1 reference

Journal of Dermatological Treatment

18 August 2017

published in

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

18 August 2017

page(s)

5-21

1 reference

Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Death from psoriasis: representative US data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

An Italian study on psoriasis and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Epidemiology of psoriatic arthritis in the population of the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Psoriasis causes as much disability as other major medical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Disease concomitance in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Metabolic disorders in patients with psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Psychiatric illness in patients referred to a dermatology-psychiatry clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Psychiatric morbidity in psoriasis and vitiligo: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Quality of life in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Assessment of depression in subjects with psoriasis vulgaris and lichen planus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Cytokines and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Malignant tumours and psoriasis: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Psoriasis and occlusive vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The comorbid state of psoriasis patients in a university dermatology practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Review article: adipocytokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Serum lipid levels in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Lipid profile, insulin secretion, and insulin sensitivity in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Serum lipids and apolipoproteins in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The variation of serum lipoprotein (a) level with disease activity in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Comparison of various insulin sensitivity indices in psoriatic patients and their relationship with type of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Weight Change and Diabetes Incidence: Findings from a National Cohort of US Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Components of the "metabolic syndrome" and incidence of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The inflammatory response in mild and in severe psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The evolving role of inflammation in obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-gamma and extracellularly regulated k

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Requirement for leptin in the induction and progression of autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Fatty acids as modulators of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Lipoproteins modulate growth and differentiation of cultured human epidermal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Insulin resistance and impaired beta cell function in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The role of TNF-alpha in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Protection from obesity-induced insulin resistance in mice lacking TNF-α function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Influence of TNF-alpha and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The TNF-α Gene Neo I Polymorphism Influences the Relationship Among Insulin Resistance, Percent Body Fat, and Increased Serum Leptin Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The TNF-alpha gene NcoI polymorphism at position -308 of the promoter influences insulin resistance, and increases serum triglycerides after postprandial lipaemia in familiar obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The insulin resistance syndrome and the binding capacity of cortisol binding globulin (CBG) in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Free fatty acids-the link between obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Why visceral fat is bad: mechanisms of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Psoriasis and sex: a study of moderately to severely affected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Relationship between smoking and the clinical severity of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Alcohol intake: a risk factor for psoriasis in young and middle aged men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

SLE, atherosclerosis and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Rheumatoid arthritis: a disease associated with accelerated atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Oxidant stress, inflammation and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Autoimmunity, oxidized LDL and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Dual role of oxidized LDL on the NF-kappaB signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Tumor necrosis factor enhances low density lipoprotein oxidative modification by monocytes and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Homocysteine and atherothrombosis--mechanisms for injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Effects of etanercept in patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Intravascular tumor necrosis factor α blockade reverses endothelial dysfunction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long‐term infliximab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701364768

10.1080/09546630701364768

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference